Source: Frontiers in Immunology. Unidades: FCFRP, FMRP
Subjects: RECEPTORES, INTERLEUCINAS, ADENOSINA TRIFOSFATO, LEUCOTRIENOS B, VENENOS
ABNT
ZOCCAL, Karina F. et al. CD36 shunts eicosanoid metabolism to repress CD14 licensed interleukin-1β release and inflammation. Frontiers in Immunology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2018.00890. Acesso em: 28 ago. 2024.APA
Zoccal, K. F., Gardinassi, L. G., Sorgi, C. A., Meirelles, A. F. G., Bordon, K. de C. F., Glezer, I., et al. (2018). CD36 shunts eicosanoid metabolism to repress CD14 licensed interleukin-1β release and inflammation. Frontiers in Immunology, 9. doi:10.3389/fimmu.2018.00890NLM
Zoccal KF, Gardinassi LG, Sorgi CA, Meirelles AFG, Bordon K de CF, Glezer I, Cupo P, Matsuno AK, Bollela VR, Arantes EC, Guimarães FS, Faccioli LH. CD36 shunts eicosanoid metabolism to repress CD14 licensed interleukin-1β release and inflammation [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 ago. 28 ] Available from: https://doi.org/10.3389/fimmu.2018.00890Vancouver
Zoccal KF, Gardinassi LG, Sorgi CA, Meirelles AFG, Bordon K de CF, Glezer I, Cupo P, Matsuno AK, Bollela VR, Arantes EC, Guimarães FS, Faccioli LH. CD36 shunts eicosanoid metabolism to repress CD14 licensed interleukin-1β release and inflammation [Internet]. Frontiers in Immunology. 2018 ; 9[citado 2024 ago. 28 ] Available from: https://doi.org/10.3389/fimmu.2018.00890